vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and ServisFirst Bancshares, Inc. (SFBS). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $159.0M, roughly 1.7× ServisFirst Bancshares, Inc.). ServisFirst Bancshares, Inc. runs the higher net margin — 52.2% vs 0.7%, a 51.5% gap on every dollar of revenue.

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

ServisFirst Bancshares, Inc. is a U.S.-based bank holding company operating full-service banking locations primarily across the Southeastern United States. It offers a full suite of commercial banking, consumer banking, wealth management, and mortgage lending services to small and medium-sized businesses, professional clients, and individual consumers.

HCM vs SFBS — Head-to-Head

Bigger by revenue
HCM
HCM
1.7× larger
HCM
$270.8M
$159.0M
SFBS
Higher net margin
SFBS
SFBS
51.5% more per $
SFBS
52.2%
0.7%
HCM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HCM
HCM
SFBS
SFBS
Revenue
$270.8M
$159.0M
Net Profit
$2.0M
$83.0M
Gross Margin
37.7%
Operating Margin
-13.2%
Net Margin
0.7%
52.2%
Revenue YoY
-16.5%
Net Profit YoY
-83.6%
31.2%
EPS (diluted)
$0.00
$1.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
SFBS
SFBS
Q1 26
$159.0M
Q4 25
$270.8M
$162.2M
Q3 25
$136.3M
Q2 25
$277.7M
$132.1M
Q1 25
$324.5M
$131.8M
Q4 24
$131.9M
Q3 24
$123.7M
Q2 24
$305.7M
$114.8M
Net Profit
HCM
HCM
SFBS
SFBS
Q1 26
$83.0M
Q4 25
$2.0M
$86.4M
Q3 25
$65.6M
Q2 25
$455.0M
$61.4M
Q1 25
$11.9M
$63.2M
Q4 24
$65.2M
Q3 24
$59.9M
Q2 24
$25.8M
$52.1M
Gross Margin
HCM
HCM
SFBS
SFBS
Q1 26
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Operating Margin
HCM
HCM
SFBS
SFBS
Q1 26
Q4 25
-13.2%
66.3%
Q3 25
57.8%
Q2 25
-1.3%
58.0%
Q1 25
-5.0%
60.0%
Q4 24
60.2%
Q3 24
58.5%
Q2 24
-9.0%
58.0%
Net Margin
HCM
HCM
SFBS
SFBS
Q1 26
52.2%
Q4 25
0.7%
59.0%
Q3 25
48.1%
Q2 25
163.8%
46.5%
Q1 25
3.7%
48.0%
Q4 24
52.9%
Q3 24
48.4%
Q2 24
8.4%
45.4%
EPS (diluted)
HCM
HCM
SFBS
SFBS
Q1 26
$1.52
Q4 25
$0.00
$1.58
Q3 25
$1.20
Q2 25
$0.52
$1.12
Q1 25
$0.01
$1.16
Q4 24
$1.19
Q3 24
$1.10
Q2 24
$0.03
$0.95

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
SFBS
SFBS
Cash + ST InvestmentsLiquidity on hand
$1.4B
$1.8B
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$1.9B
Total Assets
$1.8B
$18.2B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
SFBS
SFBS
Q1 26
$1.8B
Q4 25
$1.4B
Q3 25
Q2 25
$1.4B
Q1 25
$836.1M
Q4 24
Q3 24
Q2 24
$802.5M
Total Debt
HCM
HCM
SFBS
SFBS
Q1 26
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Stockholders' Equity
HCM
HCM
SFBS
SFBS
Q1 26
$1.9B
Q4 25
$1.2B
$1.8B
Q3 25
$1.8B
Q2 25
$1.2B
$1.7B
Q1 25
$759.9M
$1.7B
Q4 24
$1.6B
Q3 24
$1.6B
Q2 24
$740.1M
$1.5B
Total Assets
HCM
HCM
SFBS
SFBS
Q1 26
$18.2B
Q4 25
$1.8B
$17.7B
Q3 25
$17.6B
Q2 25
$1.8B
$17.4B
Q1 25
$1.3B
$18.6B
Q4 24
$17.4B
Q3 24
$16.4B
Q2 24
$1.3B
$16.0B
Debt / Equity
HCM
HCM
SFBS
SFBS
Q1 26
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
SFBS
SFBS
Operating Cash FlowLast quarter
$8.2M
Free Cash FlowOCF − Capex
$3.4M
FCF MarginFCF / Revenue
1.2%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
SFBS
SFBS
Q1 26
Q4 25
$8.2M
$355.2M
Q3 25
$140.9M
Q2 25
$-72.9M
$67.6M
Q1 25
$40.3M
$48.0M
Q4 24
$252.9M
Q3 24
$84.0M
Q2 24
$-39.8M
$48.3M
Free Cash Flow
HCM
HCM
SFBS
SFBS
Q1 26
Q4 25
$3.4M
Q3 25
Q2 25
$-82.2M
Q1 25
$32.5M
Q4 24
Q3 24
Q2 24
$-49.9M
FCF Margin
HCM
HCM
SFBS
SFBS
Q1 26
Q4 25
1.2%
Q3 25
Q2 25
-29.6%
Q1 25
10.0%
Q4 24
Q3 24
Q2 24
-16.3%
Capex Intensity
HCM
HCM
SFBS
SFBS
Q1 26
Q4 25
1.8%
Q3 25
Q2 25
3.3%
Q1 25
2.4%
Q4 24
Q3 24
Q2 24
3.3%
Cash Conversion
HCM
HCM
SFBS
SFBS
Q1 26
Q4 25
4.21×
4.11×
Q3 25
2.15×
Q2 25
-0.16×
1.10×
Q1 25
3.38×
0.76×
Q4 24
3.88×
Q3 24
1.40×
Q2 24
-1.54×
0.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

SFBS
SFBS

Net Interest Income$148.1M93%
Noninterest Income$10.8M7%

Related Comparisons